Immune status following alemtuzumab treatment in human CD52 transgenic mice
Autor: | Turner, Michael J., LaMorte, Michael J., Chretien, Nathalie, Havari, Evis, Roberts, Bruce L., Kaplan, Johanne M., Siders, William M. |
---|---|
Zdroj: | In Journal of Neuroimmunology 15 August 2013 261(1-2):29-36 |
Databáze: | ScienceDirect |
Externí odkaz: |